The advent of massively parallel sequencing by next generation sequencing platforms now allow genomic approaches for individualizing healthcare. Genomic sequencing data reveals variants in genes related to drug metabolism that may affect efficacy or response. This presentation will describe the potential of NGS data for companion diagnostics or therapeutics and its implementation into clinical laboratories. Evaluating pharmacogenetic targets through exome analysis as well as through targeted gene panels will be discussed.
Modern laboratories are under constant pressure to deliver results faster, more accurately, and with unwavering compliance. Organizations that harness next-generation LIMS capabilities gain...
Alors que les soins de santé continuent d'évoluer vers des modèles accessibles et centrés sur le patient, les pharmacies de détail apparaissent comme d...
With advancing food allergy research and emerging therapies, new allergy testing requirements arise. In this context, Basophil Activation Testing (BAT) has emerged as an essential component...
Energy-efficient filtration solutions that reduce hidden chemical exposure from benchtop work and lab equipment to improve overall laboratory safety...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly among children with autism spectrum disorder (ASD) and other neu...
The timing of the biological onset of multiple sclerosis (MS) is unclear. We used high-throughput discovery proteomics and samples from presymptomatic patients with MS and matched healthy co...
Loading Comments...
Please update your information
Certificate of Participation
Thank you for choosing Labroots. Please note that a Certificate of Participation does NOT count towards Continuing Education Credits.